---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-036161"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2022-12-21T23:59:59+00:00"
generated_at: "2026-06-21T00:45:26.132168+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Stephen LaNeve resigns from Bone Biologics board

## Summary
- Stephen LaNeve resigned as a director effective December 18, 2022.
- Resignation was not due to any disagreement with the company's operations, policies, or practices.
- Company expressed appreciation for Mr. LaNeve's years of service.

## SEC filing metadata
- accession: 0001493152-22-036161
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2022-12-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315222036161/0001493152-22-036161-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315222036161/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-036161
- JSON: https://secwatch.observer/filing/0001493152-22-036161.json
- Plain text: https://secwatch.observer/filing/0001493152-22-036161.txt

## Key facts
- Executive change
  Stephen LaNeve resigned as director at Bone Biologics Corp.
  - Action: resigned
  - Role: director
  source text: Effective December 18, 2022 Stephen LaNeve resigned as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315222036161/0001493152-22-036161-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.